Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
European Urology
|
March 21, 2017
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Marco Moschini, Peter R Carroll, Scott E Eggener, et al.
Advances in Therapy
|
March 22, 2023
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States
Christopher Parker, Fei Fei Liu, Kristen A Deger, et al.
JAMA Oncology
|
October 17, 2018
Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review
, Christopher Parker, Valerie Lewington, et al.
The American Journal of Emergency Medicine
|
September 22, 2023
Comparison of dynamic versus static ultrasound to confirm endotracheal tube depth
Michael Gottlieb, Nicholas Cozzi, Molly Hartrich, et al.
The Prostate
|
March 24, 2016
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA
Oliver Sartor, Peter Hoskin, Robert E Coleman, et al.
Journal of Medical Economics
|
July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland
Christopher Parker, Beth Woods, James Eaton, et al.
Frontiers in Oncology
|
February 13, 2015
The war on cancer: a military perspective
Bryan Oronsky, Corey A Carter, Vernon Mackie, et al.
European Urology Focus
|
February 4, 2016
The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update
Ahmed El-Shater Bosaily, Christopher Parker, Louise C Brown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 2016
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial
Christopher Parker, Lin Zhan, Paul Cislo, et al.
The Medical Journal of Australia
|
October 22, 2014
Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome
Christopher Parker, Steven Y C Tong, Karen Dempsey, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
European Urology
|
March 21, 2017
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Marco Moschini, Peter R Carroll, Scott E Eggener, et al.
Advances in Therapy
|
March 22, 2023
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States
Christopher Parker, Fei Fei Liu, Kristen A Deger, et al.
JAMA Oncology
|
October 17, 2018
Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review
, Christopher Parker, Valerie Lewington, et al.
The American Journal of Emergency Medicine
|
September 22, 2023
Comparison of dynamic versus static ultrasound to confirm endotracheal tube depth
Michael Gottlieb, Nicholas Cozzi, Molly Hartrich, et al.
The Prostate
|
March 24, 2016
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA
Oliver Sartor, Peter Hoskin, Robert E Coleman, et al.
Journal of Medical Economics
|
July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland
Christopher Parker, Beth Woods, James Eaton, et al.
Frontiers in Oncology
|
February 13, 2015
The war on cancer: a military perspective
Bryan Oronsky, Corey A Carter, Vernon Mackie, et al.
European Urology Focus
|
February 4, 2016
The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update
Ahmed El-Shater Bosaily, Christopher Parker, Louise C Brown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 2016
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial
Christopher Parker, Lin Zhan, Paul Cislo, et al.
The Medical Journal of Australia
|
October 22, 2014
Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome
Christopher Parker, Steven Y C Tong, Karen Dempsey, et al.
Page
of 8